Veterinary Medicine Information website

DEXAFORT (1,32+2,67)MG/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Not authorised
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
DEXAFORT (1,32+2,67)MG/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Target species:
  • Horse
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
    2.67
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        47
        day
    • Cattle
      • Meat and offal
        53
        day
      • Milk
        7
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 37940/3-10-2000/K-0129201
Date of authorisation status change: